Ardian to sell Groupe Bio7 to Cerba HealthCare

Ardian has agreed to sell Groupe Bio7, a French clinical pathology company, to Cerba HealthCare. No financial terms were disclosed.

26 March 2018•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles